Journal Mobile Options
Table of Contents
Vol. 37, No. 4, 2005
Issue release date: July–August 2005
Ophthalmic Res 2005;37:202–213
(DOI:10.1159/000086610)

Minocycline Partially Inhibits Caspase-3 Activation and Photoreceptor Degeneration after Photic Injury

Chang C.-J. · Cherng C.-H. · Liou W.-S. · Liao C.-L.
Departments of aOphthalmology and bPharmacy Practice, Tri-Service General Hospital, Taipei; Departments of cMedical Sciences and dMicrobiology and Immunology, National Defense Medical Center, Taipei, Taiwan, ROC

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Purpose: To evaluate the possible role of caspase-3 in retinal photic injury, and to investigate whether minocycline can ameliorate light-induced photoreceptor degeneration. Methods: Retinal photic injury was induced in rats by exposure to intense light. Expression of caspase-3 was studied using Western blot analysis, immunohistochemical staining and enzyme activity assay. Apoptotic photoreceptor cells were detected by the TdT-dUTP terminal nick-end labeling (TUNEL) method. Minocycline (15, 30 or 45 mg/kg) was administered before or after photic injury in rats randomly assigned to pretreatment and posttreatment groups. Minocycline and vehicle-treated retinas subjected to photic injury were compared with respect to Western blotting, enzyme activity assay, quantitative counts of TUNEL stains, morphometry of the outer nuclear layer (ONL) thickness and histopathological examination. Results: After light exposure, active caspase-3 and poly-adenosine diphosphate-ribose-polymerase were upregulated in the retinas and increased caspase-3 immunoreactivity was observed in the ONL. Caspase-3 enzyme activity increased in the retinas that underwent photic injury, and this increase was significantly reduced in minocycline pretreated (30 and 45 mg/kg) and posttreated (45 mg/kg) groups. Intraperitoneal administration of minocycline before or after photic injury in rats also resulted in less TUNEL-positive photoreceptors, as assessed by the quantitative TUNEL counts. The degree of retinal degeneration, measured by the ONL thickness 14 days after photic injury, was significantly improved in minocycline pretreatment (45 mg/kg) rats. Conclusions: We demonstrate that increased caspase-3 activities localize specifically within the ONL after photic injury, and that minocycline partially inhibits caspase-3 activation and photoreceptor degeneration in this animal model.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Grimm C, Wenzel A, Hafezi F, et al: Gene expression in the mouse retina: The effect of damaging light. Mol Vis 2000;6:252–260.
  2. Wu T, Chen Y, Chiang SK, et al: NF-kappaB activation in light-induced retinal degeneration in a mouse model. Invest Ophthalmol Vis Sci 2002;43:2834–2840.
  3. Edward DP, Lam TT, Shahinfar S, et al: Amelioration of light-induced retinal degeneration by a calcium overload blocker. Flunarizine. Arch Ophthalmol 1991;109:554–562.
  4. Rosner M, Lam TT, Fu J, et al: Methylprednisolone ameliorates retinal photic injury in rats. Arch Ophthalmol 1992;110:857–861.
  5. Lam TT, Abler AS, Kwong JM, et al: N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 1999;40:2391–2397.
  6. Organisciak DT, Darrow RA, Barsalou L, et al: Light-induced damage in the retina: Differential effects of dimethylthiourea on photoreceptor survival, apoptosis and DNA oxidation. Photochem Photobiol 1999;70:261–268.
  7. Yu X, Rajala RV, McGinnis JF, et al: Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem 2004;279:13086–13094.
  8. Cao W, Tombran-Tink J, Elias R, et al: In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001;42:1646–1652.
  9. Abler AS, Chang CJ, Ful J, et al: Photic injury triggers apoptosis of photoreceptor cells. Res Commun Mol Pathol Pharmacol 1996;92:177–189.
  10. Li S, Chang CJ, Abler AS, et al: A comparison of continuous versus intermittent light exposure on apoptosis. Curr Eye Res 1996;15:914–922.
  11. Chang CJ, Lai WW, Edward DP, et al: Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol 1995;113:880–886.
  12. Friedlander RM: Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003;348:1365–1375.
  13. Tezel G, Wax MB: Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci 1999;40:2660–2667.
  14. Singh M, Savitz SI, Hoque R, et al: Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J Neurochem 2001;77:466–475.
  15. Wu J, Gorman A, Zhou X, et al: Involvement of caspase-3 in photoreceptor cell apoptosis induced by in vivo blue light exposure. Invest Ophthalmol Vis Sci 2002;43:3349–3354.
  16. Kim DH, Kim JA, Choi JS, et al: Activation of caspase-3 during degeneration of the outer nuclear layer in the rd mouse retina. Ophthalmic Res 2002;34:150–157.
  17. Lam TT, Abler AS, Tso MO: Apoptosis and caspases after ischemia-reperfusion injury in rat retina. Invest Ophthalmol Vis Sci 1999;40:967–975.
  18. Katai N, Yoshimura N: Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci 1999;40:2697–2705.
  19. Thomas M, Le WD, Jankovic J: Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson’s disease and Huntington’s disease. Clin Neuropharmacol 2003;26:18–23.
  20. Bonelli RM, Heuberger C, Reisecker F: Minocycline for Huntington’s disease: An open label study. Neurology 2003;60:883–884.
  21. Yrjanheikki J, Keinanen R, Pellikka M, et al: Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998;95:15769–15774.
  22. Yrjanheikki J, Tikka T, Keinanen R, et al: A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999;96:13496–13500.
  23. Sanchez Mejia RO, Ona VO, Li M, et al: Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001;48:1393–1399.
  24. Kriz J, Nguyen MD, Julien JP: Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2002;10:268–278.
  25. Du Y, Ma Z, Lin S, et al: Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease. Proc Natl Acad Sci USA 2001;98:14669–14674.
  26. Erickson RP, Bernard O: Studies on neuronal death in the mouse model of Niemann-Pick C disease. J Neurosci Res 2002;68:738–744.
  27. Tikka T, Fiebich BL, Goldsteins G, et al: Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001;21:2580–2588.
  28. Chen M, Ona VO, Li M, et al: Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000;6:797–801.
  29. Shahinfar S, Edward DP, Tso MO: A pathologic study of photoreceptor cell death in retinal photic injury. Curr Eye Res 1991;10:47–59.
  30. Arvin KL, Han BH, Du Y, et al: Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 2002;52:54–61.
  31. Seiler MJ, Liu OL, Cooper NG, et al: Selective photoreceptor damage in albino rats using continuous blue light. A protocol useful for retinal degeneration and transplantation research. Graefes Arch Clin Exp Ophthalmol 2000;238:599–607.
  32. Hafezi F, Marti A, Munz K, et al: Light-induced apoptosis: Differential timing in the retina and pigment epithelium. Exp Eye Res 1997;64:963–970.
  33. Enari M, Talanian RV, Wong WW, et al: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723–726.
  34. Kang SJ, Wang S, Hara H, et al: Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 2000;149:613–622.
  35. Hengartner MO: The biochemistry of apoptosis. Nature 2000;407:770–776.
  36. Tewari M, Quan LT, O’Rourke K, et al: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801–809.
  37. Donovan M, Cotter TG: Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ 2002;9:1220–1231.
  38. Donovan M, Carmody RJ, Cotter TG: Light-induced photoreceptor apoptosis in vivo requires neuronal nitric-oxide synthase and guanylate cyclase activity and is caspase-3-inde pendent. J Biol Chem 2001;276:23000– 23008.
  39. Enochs WS, Nilges MJ, Swartz HM: The minocycline-induced thyroid pigment and several synthetic models: Identification and characterization by electron paramagnetic reso nance spectroscopy. J Pharmacol Exp Ther 1993;266:1164–1176.
  40. Bowles WH: Protection against minocycline pigment formation by ascorbic acid (vitamin C). J Esthet Dent 1998;10:182–186.
  41. Miyachi Y, Yoshioka A, Imamura S, et al: Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986;86:449–453.
  42. Akamatsu H, Asada M, Komura J, et al: Effect of doxycycline on the generation of reactive oxygen species: A possible mechanism of action of acne therapy with doxycycline. Acta Derm Venereol 1992;72:178–179.
  43. Kluck RM, Bossy-Wetzel E, Green DR, et al: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132–1136.
  44. Kirsch DG, Doseff A, Chau BN, et al: Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 1999;274:21155–21161.
  45. Zhu S, Stavrovskaya IG, Drozda M, et al: Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002;417:74–78.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50